Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inne H M Borel-Rinkes

Showing results (181-190 of 215) with videos related to

Pageof 22
Sort By:
Journal of Surgical Oncology|August 12, 2019
Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG)Dirk-Jan van Beek, Sjoerd Nell, Carolina R C Pieterman, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2021
Adult mouse and human organoids derived from thyroid follicular cells and modeling of Graves' hyperthyroidismJelte van der Vaart, Lynn Bosmans, Stijn F Sijbesma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 12, 2012
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumorsRoeland F de Wilde, Christopher M Heaphy, Anirban Maitra, et al.
The Journal of Clinical Endocrinology and Metabolism|August 7, 2015
No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1Sjoerd Nell, Rachel S van Leeuwaarde, Carolina R C Pieterman, et al.
Surgery|March 28, 2022
Risk factors for complications after surgery for pancreatic neuroendocrine tumorsDirk-Jan van Beek, Tim J Takkenkamp, Edgar M Wong-Lun-Hing, et al.
Cancers|May 28, 2022
External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide CohortKaren Bolhuis, G Emerens Wensink, Marloes A G Elferink, et al.
Cancer Research|May 16, 2022
Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic StageMaria C Heinz, Niek A Peters, Koen C Oost, et al.
Neuroendocrinology|July 30, 2020
Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based CohortDirk-Jan van Beek, Helena M Verkooijen, Sjoerd Nell, et al.
Annals of Surgical Oncology|September 26, 2024
Reclassification of Appendiceal Mucinous Neoplasms and Associated Pseudomyxoma Peritonei According to the Peritoneal Surface Oncology Group International Consensus: Clinicopathological Reflections of a Two-Center Cohort StudyPaulien Rauwerdink, Dania Al-Toma, Emma C E Wassenaar, et al.
European Journal of Endocrinology|January 10, 2015
Thyroid incidentalomas in patients with multiple endocrine neoplasia type 1Lutske Lodewijk, Pim J Bongers, Jakob W Kist, et al.
Pageof 22

Showing results (181-190 of 215) with videos related to

Sort By:
Pageof 22
Journal of Surgical Oncology|August 12, 2019
Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG)Dirk-Jan van Beek, Sjoerd Nell, Carolina R C Pieterman, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2021
Adult mouse and human organoids derived from thyroid follicular cells and modeling of Graves' hyperthyroidismJelte van der Vaart, Lynn Bosmans, Stijn F Sijbesma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 12, 2012
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumorsRoeland F de Wilde, Christopher M Heaphy, Anirban Maitra, et al.
The Journal of Clinical Endocrinology and Metabolism|August 7, 2015
No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1Sjoerd Nell, Rachel S van Leeuwaarde, Carolina R C Pieterman, et al.
Surgery|March 28, 2022
Risk factors for complications after surgery for pancreatic neuroendocrine tumorsDirk-Jan van Beek, Tim J Takkenkamp, Edgar M Wong-Lun-Hing, et al.
Cancers|May 28, 2022
External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide CohortKaren Bolhuis, G Emerens Wensink, Marloes A G Elferink, et al.
Cancer Research|May 16, 2022
Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic StageMaria C Heinz, Niek A Peters, Koen C Oost, et al.
Neuroendocrinology|July 30, 2020
Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based CohortDirk-Jan van Beek, Helena M Verkooijen, Sjoerd Nell, et al.
Annals of Surgical Oncology|September 26, 2024
Reclassification of Appendiceal Mucinous Neoplasms and Associated Pseudomyxoma Peritonei According to the Peritoneal Surface Oncology Group International Consensus: Clinicopathological Reflections of a Two-Center Cohort StudyPaulien Rauwerdink, Dania Al-Toma, Emma C E Wassenaar, et al.
European Journal of Endocrinology|January 10, 2015
Thyroid incidentalomas in patients with multiple endocrine neoplasia type 1Lutske Lodewijk, Pim J Bongers, Jakob W Kist, et al.
Pageof 22